Vericel Corp SEC filings VCEL

Vericel Corp has 1,002 filings in SEC EDGAR's recent list, going back to Aug 7, 2013. Its latest annual report, Form ARS, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Vericel Corp SEC filings
Form Description Filed Period
S-8 Employee stock plan registration May 8, 2025 —
S-8 Employee stock plan registration May 8, 2025 —
S-3ASR Automatic shelf registration Aug 16, 2024 —
S-8 Employee stock plan registration May 22, 2023 —
S-8 POS Filing May 6, 2022 —
S-8 POS Filing May 6, 2022 —
S-8 Employee stock plan registration May 6, 2022 —
S-3ASR Automatic shelf registration Aug 27, 2021 —
S-8 Employee stock plan registration Aug 6, 2020 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 POS Filing May 1, 2019 —
S-8 Employee stock plan registration May 1, 2019 —
S-3 Shelf registration Aug 16, 2018 —
424B5 Prospectus supplement Jun 1, 2018 —
S-3MEF Filing May 31, 2018 —
424B5 Prospectus supplement May 30, 2018 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 POS Filing Aug 9, 2017 —
S-8 Employee stock plan registration May 5, 2017 —
424B5 Prospectus supplement Dec 16, 2016 —
424B5 Prospectus supplement Dec 16, 2016 —
424B5 Prospectus supplement Oct 11, 2016 —
424B5 Prospectus supplement Jul 29, 2015 —
424B3 Prospectus Jul 16, 2015 —
424B3 Prospectus Jul 16, 2015 —
424B3 Prospectus Jul 16, 2015 —
POS AM Filing Jun 29, 2015 —
POS AM Filing Jun 29, 2015 —
S-3 Shelf registration Jun 29, 2015 —
S-8 Employee stock plan registration Jun 29, 2015 —
S-3 Shelf registration Jun 29, 2015 —
424B5 Prospectus supplement Nov 14, 2014 —
424B5 Prospectus supplement Nov 14, 2014 —
424B5 Prospectus supplement Sep 17, 2014 —
424B5 Prospectus supplement Sep 17, 2014 —
424B4 Prospectus Sep 11, 2014 —
S-1/A Amended registration statement Sep 8, 2014 —
424B5 Prospectus supplement Sep 3, 2014 —
424B5 Prospectus supplement Sep 3, 2014 —
S-1/A Amended registration statement Sep 2, 2014 —
424B5 Prospectus supplement Aug 15, 2014 —
424B5 Prospectus supplement Aug 15, 2014 —
S-1 Registration statement Aug 6, 2014 —
424B5 Prospectus supplement Jun 27, 2014 —
424B5 Prospectus supplement Jun 16, 2014 —
424B5 Prospectus supplement Jun 16, 2014 —
424B5 Prospectus supplement May 19, 2014 —
424B5 Prospectus supplement May 19, 2014 —
424B5 Prospectus supplement May 16, 2014 —
424B5 Prospectus supplement May 16, 2014 —
424B5 Prospectus supplement May 12, 2014 —
424B5 Prospectus supplement May 12, 2014 —
424B5 Prospectus supplement May 5, 2014 —
424B5 Prospectus supplement May 5, 2014 —
424B5 Prospectus supplement Apr 25, 2014 —
424B5 Prospectus supplement Apr 25, 2014 —
424B3 Prospectus Apr 4, 2014 —
424B3 Prospectus Apr 3, 2014 —
S-1/A Amended registration statement Mar 26, 2014 —
424B5 Prospectus supplement Mar 21, 2014 —
S-1 Registration statement Feb 10, 2014 —
424B5 Prospectus supplement Nov 29, 2013 —
424B5 Prospectus supplement Aug 14, 2013 —
S-1/A Amended registration statement Aug 13, 2013 —
S-1/A Amended registration statement Aug 13, 2013 —
S-1/A Amended registration statement Aug 12, 2013 —
S-1/A Amended registration statement Aug 8, 2013 —
FWP Free writing prospectus Aug 7, 2013 —

Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VCEL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MI
Headquarters
Burlington, MA
SEC filer status
Large accelerated filer
SEC CIK
887359
Former names
AASTROM BIOSCIENCES INC (until Nov 14, 2014)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.